education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
MIMS home
Drugs
Info
Lanpepsa
Lanpepsa
sucralfate
Manufacturer:
Landson
Marketer:
Landson
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Sucralfate
Indications/Uses
Short-term treatment (up to 8 wk) of duodenal ulcer.
Dosage/Direction for Use
Adult
10 mL 4 times daily.
Administration
Should be taken on an empty stomach: Take 1 hr before meals & at bedtime.
Contraindications
Hypersensitivity.
Adverse Reactions
Constipation; dry mouth. Diarrhea, nausea, vomiting, abdominal discomfort, flatulence; pruritus, rash; drowsiness, dizziness; back pain, headache.
View
ADR Reporting Link
Drug Interactions
Reduced absorption of cimetidine, ciprofloxacin, digoxin, ketoconazole, norfloxacin, phenytoin, ranitidine, tetracycline & theophylline.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02BX02 - sucralfate ; Belongs to the class of other drugs used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Regulatory Classification
K
Presentation/Packing
Form
Lanpepsa oral susp 500 mg/5 mL
Packing/Price
120 mL x 1's (Rp44,000/botol)
Daftar Gratis untuk melanjutkan membaca
Sumber terlengkap se-Asia untuk informasi medis, referensi klinis, dan pendidikan
Lanjutkan dengan Google
ATAU
Daftar dengan email
Sudah punya akun?
Masuk